P27kip is a key inhibitory protein of the cell-cycle progression, which is rapidly downregulated in early G1 phase by a post-translational mechanism involving the proteosomal degradation. In this study, using a wounding model that induces cell-cycle entry of human dermal fibroblasts, we demonstrate that p27mRNA is downregulated when cells progress into the G1 phase, and then it returns to its basal level when cells approach the S phase. By using a quantitative polymerase chain reaction screening we identified inhibitors of differentiation (Id3), a bHLH transcriptional repressor, as a candidate mediator accounting for p27 mRNA decrease. Id3 silencing, using an small interfering RNA approach, reversed the injury mediated p27 downregulation demonstrating that Id3 is involved in the transcriptional repression of p27. Reporter gene experiments and a chromatin immunoprecipitation assay showed that Id3 likely exerts its repressive action through ELK1 inhibition. By inhibiting early p27 downregulation, Id3 depletion blocked (i) the G1-phase progression as assessed by the inhibition of pRb phosphorylation and p130 degradation and (ii) the G1/S transition as observed by the inhibition of cyclin A induction, demonstrating that p27 mRNA decrease is required for cell proliferation. Apart from its effect on the early p27 diminution, Id3 appears also involved in the control of the steady-state level of p27 at the G1/S boundary. In conclusion, this study identifies a novel mechanism of p27 regulation which besides p27 protein degradation also implicates a transcriptional mechanism mediated by Id3.
Introduction
Most adult tissues are constituted by differentiated cells with reduced proliferative activity. Renewal and/or regeneration of these tissues is supplied by quiescent cells sensitive to mitogenic signals. During the skin wound healing process, the proliferation of quiescent cells can be stimulated by signals such as serum afflux and/or contact inhibition failure.
'Inhibitors of differentiation' (Id) proteins are early genes that operate as regulators of cell fate determination. They play a crucial role in the coordinated regulation of gene expression during cell growth, differentiation and tumorigenesis (Norton, 2000; Benezra et al., 2001) . The involvement of Ids was also recently shown in cellular senescence (Alani et al., 2001; Ohtani et al., 2001; Zheng et al., 2004) and in the fate of specialized cells such as lymphocytes, vascular endothelial cells and neurons (Lyden et al., 1999; Benezra et al., 2001; Engel and Murre, 2001) .
Today, four members of the Id protein family (Id1-Id4) have been identified. They directly associate with and regulate the activity of several families of transcriptional regulators (Yates et al., 1999; Lasorella et al., 2000; Norton, 2000; Roberts et al., 2001) . In mammals, Id proteins exert their biological effects mainly through the interaction with bHLH transcription factors by blocking their DNA-binding activity. Among the Id3 partners, the members of the E2A family of transcription factors (E12, E47) are the most frequently described (Massari and Murre, 2000; Norton, 2000) . However, they are not the exclusive partners of Id3 as it has also been shown that Id3 also interacts with MyoD, Ets, Pax or TCFs Ets-domain transcription factors (Yates et al., 1999; Roberts et al., 2001; Trausch-Azar et al., 2004) . Ids proteins lack a basic DNA-binding domain and readily associate with transcription factors of the bHLH family such as E proteins to inhibit their DNA-binding function.
Recent data have demonstrated that Ids activity is inhibited by cell-cycle-dependent kinase activities such as cyclin E-and A-CDK2 (Deed et al., 1997) . In addition, it has also been shown that E2A and Ids proteins participate to the transcriptional regulation of the cyclin-dependent kinase inhibitors (CKIs) p21 ink4a (Id1) (Zheng et al., 2004) in different biological models including senescence. Recent studies have shown that besides p21 and p16, Id1 and Id3 are also involved in the regulation of p27 protein, notably in Xenopus neural crest progenitors (Kee and Bronner-Fraser, 2005) and in Epstein-Barr virus infected cells (Everly et al., 2004) ; however, the molecular basis of this inhibition has never been elucidated.
The CKI p27kip1 is a key regulator of cell-cycle commitment and progression. P27 is downregulated when cells are stimulated with mitotic agents and it is induced to play a key role in mediating G1 arrest in response to mitogen starvation, cell confluence or transforming growth factor b (Sherr and Roberts, 1995) . It is well established that p27 expression is mainly posttranslationally regulated by the ubiquitin-proteasome pathway (Pagano et al., 1995; Montagnoli et al., 1999; Malek et al., 2001; Kamura et al., 2004) . However, some studies demonstrate that p27 might also be transcriptionally regulated (Servant et al., 2000; Sakakibara et al., 2005) . Nevertheless, at present, the mechanisms involved in such regulation remain unidentified.
Dermal fibroblast proliferation is a major feature of cutaneous wound healing (Martin, 1997) , which is altered in several pathologies such as keloids (Calderon et al., 1996) and chronic wounds, which can evoluate toward cutaneous carcinoma (Loots et al., 1999; Chraibi et al., 2004) . To date the mechanisms underlying cell proliferation in the cutaneous wound healing context remain poorly understood. Using a suitable model to study in vitro wound healing (Turchi et al., 2002) , we have explored the molecular mechanisms responsible for the cell-cycle entry in wounded normal human dermal fibroblasts (HDF). We show that this process depends, at least in part, on the rapid downregulation of p27 mRNA. Using a small interfering RNA (siRNA) approach, we identify Id3 as a mediator of this effect. The silencing of Id3 abolishes the early downregulation of p27 and inhibits the cell progression in G1 as well as the G1/S transition.
Results
Wounding regulates p27 at the mRNA level and this requires the synthesis of a mediator protein We have developed an original device that creates calibrated long size injuries within confluent cell cultures. In classical conditions, this device wounds about 50% of the cell monolayer allowing the detection of a wide spectrum of molecular events (Turchi et al., 2002) . Using our wounding system, hyperconfluent dermal fibroblasts are synchronously stimulated to enter the cell-cycle (unpublished data). Using this system we have investigated the molecular mechanisms involved in the initial step of the cell-cycle entry in HDF in response to injury. We have focused our attention on p27kip1, an inhibitor of cyclin-dependent kinases (Cdk) that plays a critical role in the regulation of cell proliferation. We have precisely analysed the p27 mRNA regulation, which up to date has been poorly studied compared to the p27 protein fate.
To perform this analysis, hyperconfluent contact inhibited (CI) normal HDF were injured to stimulate cell-cycle entry and next p27 mRNA was measured by real-time quantitative PCR, before wounding and 1, 3, 6, 15 and 24 h after injury. In parallel we also analysed the expression of p27 protein by Western blot. To assess the synchronous cell-cycle entry, we measured the expression of cyclin A as a marker of the G1-S transition.
We observed that p27 mRNA was rapidly downregulated in response to injury reaching its minimal levels about 3 h after injury (Figure 1a) . About 24 h later, p27 transcript reached again its basal levels ( Figure 1a Effect of HDF injury on p27 expression: confluent HDF were stimulated to grow by mechanical injury as described in Materials and methods and harvested at the indicated times. (a) Total RNAs were isolated then p27 and cyclin A mRNA were analysed by real-time PCR using the procedure described in 'Materials and methods'. The presented experiment corresponds to a typical one chosen among six different experiments. (b) Cells were lysed and p27 protein levels were measured by Western blot. The presented experiment was chosen among four independent ones (c) Effect of cycloheximide on the downregulation of p27mRNA in wounded HDF. Confluent HDF were incubated 30 min in the absence (À) or in the presence of 5 mM cycloheximide (CHX) before injury. Wounded (W) and control (N) cells were harvested 3 h after stimulation, total RNA were extracted and p27 mRNA was measured by real-time Q-PCR. This experiment is representative of three independent experiments.
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A-A Chassot et al ( Figure 1a ). P27 protein was regulated following the same profile. It decreased between 0 and 6 h after injury and increased again around 15 h to reach its maximal levels 24 h after ( Figure 1b) . To elucidate the mechanisms responsible for p27 mRNA downregulation, we performed the same wounding experiment in the presence of cycloheximide that impairs the protein synthesis. P27 mRNA decrease was completely inhibited when cells were preincubated with cycloheximide before wounding (Figure 1c ), indicating that this regulation likely depends on the synthesis of a mediator protein stimulated in response to injury.
Id3, is a candidate regulator of p27 kip1 transcription To characterize further this intermediary molecule, we screened the expression of several transcription factors in response to injury, using a Q-PCR approach described in 'Material and methods'. Some of these genes were clearly upregulated by more than threefold (see Table 1 ) in our experimental conditions. In this context, Id3, a transcriptional repressor of bHLH transcription factors, appeared as a possible candidate to mediate the p27 mRNA diminution, as it was clearly stimulated at this time point. Indeed, Id family members (Id1-4) have been shown to regulate cell proliferation in other biological systems, notably by controlling the expression of p21cip1 and p16ink4B, two other cell-cycle inhibitors (Prabhu et al., 1997; Zheng et al., 2004) . We analysed the profile of Id3 mRNA variation in response to injury and we observed that Id3 was regulated in a biphasic manner with a maximal stimulation 1 h after injury and a second burst 24 h after injury (Figure 2a) . Western blot analysis showed that, like mRNA, Id3 protein regulation was also biphasic. Id3 was weakly expressed in confluent non-wounded cells, transiently increased 1 h after injury and raised again after 24 h (Figure 2a ).
Id3 mRNA expression was also studied in two other situations classically known to induce cell-cycle entry, namely serum (fetal calf serum (FCS)) stimulation and cell replating (Figure 2b ). Id3 mRNA was low in FCS-depleted HDF and strongly stimulated 1 h after FCS addition. The same stimulation occurred after HDF replating (Figure 2b) . A clear downregulation of p27 mRNA was also observed in these two conditions (Figure 2c ), suggesting that Id3 also regulates p27 in other situations than wound healing.
Induction of Id3 in response to cell detachment
In an attempt to find a functional signal accounting for Id3 stimulation in response to injury, we focused our attention on cell-to-cell and cell to extra cellular matrix detachment, which constitute relevant immediate events inherent to the wounding process. Confluent HDF were detached by mild trypsinization, kept for 15, 30, 45 and 60 min in suspension at 371C, then Id3 protein was measured by Western blot. The expression of Id3 increased between 30 min and 1 h after cell detachment (Figure 2d ). Id3 upregulation was completely inhibited when cells were treated with actinomycin D before trypsinization (Figure 2e ), suggesting that the upregulation of Id3 itself resulted from a transcriptional regulatory mechanism activated by injury-induced cell detachment.
Id3 is involved in injury-stimulated p27 downregulation
To investigate the potential role of Id3 in p27 downregulation, we generated a specific siRNA to deplete cells of Id3 expression. Fluorescence microscopy after transfection of Cy3-labelled Id3 demonstrated that this siRNA was efficiently incorporated in confluent HDF (60% of the cells) (not shown) and clearly inhibited Id3 mRNA expression (Figure 3a) , resulting in a decrease of the Id3 protein (60% inhibition) (Figure 3 , panel b, left and right panels). The efficiency of the Id3-siRNA was maintained during at least 24 h as shown in Figure 4a (upper graph).
Next, the effect of Id3 silencing on p27 regulation was assessed both at the mRNA and protein levels ( Figure 4a (lower panel) and b), using respectively realtime PCR and Western blot analysis. We observed that the p27 downregulation associated with the cell-cycle Abbreviations: NW, non-wounded cells; W, wounded. The first column (symbol) indicates the official symbol of the genes. Column 2 (LocusLink) indicates the 'GeneID' attributed to the genes in the LocusLink database. Column 3 shows the known molecular functions of the genes determined using Ease program (Hosack et al., 2003) . Column 4 represents the ratio between the gene expression in W versus confluent NW cells. The presented data are from a typical experiment chosen among three individual ones.
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A-A Chassot et al entry was reduced by about 50% when HDF were treated with Id3-siRNA. This effect was apparent 1, 3 and 6 h after injury ( Figure 4a ). Interestingly, 24 h after wounding, Id3 depletion further increased p27 mRNA over the basal level, suggesting that Id3 not only controls the early diminution of p27 mRNA but also triggers a signal responsible for the return of p27 to its basal level.
The Western blot analysis of p27 protein expression ( Figure 4b , lower panel) showed that Id3 silencing ( Figure 4b , upper panel) also reduced (by about 50%) the downregulation of p27 protein occurring in HDF committed into the cell-cycle after injury.
To better dissect the mechanisms of p27 mRNA regulation by Id3, we used a fragment of the p27 promoter cloned upstream the luciferase reporter gene. NIH3T3 cells were transfected with a p27 promoter construct, together with a plasmid expressing either the wild-type Id3 or a non-phosphorylable Id3-variant (Id3-Ala5), which exerts a stronger repressor activity. (Deed et al., 1997) . We detected a high basal activity of p27 promoter in NIH3T3 cells, which was inhibited by the cotransfection with the Id3 expression vector. This inhibition was enhanced when cells were transfected with Id3-Ala5, indicating that Id3 efficiently inhibits the transcriptional activity of p27 promoter (Figure 4c ).
To gain supplementary information concerning the putative Id3 partner involved in p27 transcriptional regulation, we measured p27 promoter activity in NIH3T3 cells, in the presence of constructs encoding two possible candidates: (i) the E2A family members E12 and E47 and (ii) elk1 a TCF Ets-domain transcription factor (Yates et al., 1999; Norton, 2000) . A strong promoter activity was detected in NIH3T3 when the single p27-luciferase promoter was expressed (Figure 4c , pcDNA3). Its cotransfection with plasmids encoding both E12 and E47 ( Figure 4c , E12 þ E47) did not further increase this basal activity. In contrast, a vector encoding ELK1 significantly increased the basal transcriptional activity of p27 promoter (Figure 4c , ELK1), indicating that ELK1 might be a key element in the control of p27 promoter activity. To verify the presence of Elk1-occupied sites within this promoter, we used a chromatin immunoprecipitation (ChIP) approach. Chromatin complexes were immunoprecipitated from confluent HDF extracts using an anti-ELK1 antibody. Then a PCR was performed with different primer pairs to amplify the ELK1-bound p27 promoter region. As shown in Figure 4d , PCR amplification revealed a 478 bp band corresponding to the À689/À211 region of p27 promoter (lane 3). This band was specific as it was neither detected when the immunoprecipitation was 
A-A Chassot et al performed with a non-relevant antibody (lane 1) nor with the single sepharose beads (lane 2). By analysing the p27 promoter sequence (Minami et al., 1997) , we noted the presence of an ELK1-type consensus motif (CAccGCCATATTGG) in the À453/À439 region located within the 478 bp region identified by ChIP. We therefore mutated this site and transfected NIH3T3 cells with this new mutant construct. We observed that the suppression of the elk1 site abolished more than 70% of the basal activity of p27 promoter indicating that this consensus sequence is pivotal for the regulation of the promoter activity (Figure 4e , pcDNA3/mut-p27 prom). Furthermore, the cotransfection of p27 promoter with a plasmid encoding a dominant-negative (dn) variant of Elk1 strongly inhibited the promoter activity (Figure 4e , dn-ELK1/wt-p27 prom). Then we investigated whether Id3 could be a partner of ELK1 that might antagonize its stimulatory effect on the promoter of p27. In this aim, we cotransfected the p27 promoter together with ELK1, and in the presence or absence of a plasmid encoding Id3. We observed that the elk1 stimulation of the p27 promoter activity (Figure 4e , Elk1/wt-p27 prom) was totally inhibited by the overexpression of Id3 (Figure 4e , Elk1 þ Id3/wt-p27 prom). Moreover Id3 also inhibited the basal activity of the promoter. Taken together these data indicate that ElK1 is a p27 promoter activator which activity is counterparted by Id3.
The Id3-dependent p27 downregulation is critical for cell-cycle entry We next investigated the physiological impact of Id3-dependent p27 downregulation on cell-cycle progression. In this aim, we assessed the effect of Id3 silencing on the cell-cycle commitment by analysing the effect of Id3-siRNA on two critical phases of the cell-cycle: (i) before the G1-restriction point (in early-mid-G1) namely when the pocket proteins are initially phosphorylated by cdk4/6; and (ii) after the restriction point at the G1/S transition when cells are irreversibly engaged into the cell-cycle. In this aim cells were treated with Id3-siRNA or with control-siRNA and harvested 10 and 24 h after injury. To gain information concerning the effect of siRNA on early-mid-G1 events, we first analysed the effect of Id3-siRNAs on p27 downregulation, cyclin D1 stimulation as well as on pRb phosphorylation and p130 degradation (the two major physiological substrates of cyclin D/Cdk4/6 kinases). These measures were carried out 10 h after injury (early-mid-G). We observed that Id3 silencing impaired by 50% the p27 downregulation and also decreased the phosphorylation of pRb as well as the degradation of p130 (Figure 5a ). This inhibition did not result from an inhibition of cyclin D1 stimulation, as the injury-stimulated expression of cyclin D1 was not altered after Id3 silencing compared to Ct-siRNA (Figure 5a ). Moreover and in contrast with a previous study (Prabhu et al., 1997) , in our wounding model Id3 did not control the expression of p21, another cell-cycle inhibitor (Figure 5a ).
Cyclin D1 immunoprecipitation experiments showed that, 10 h after injury, the amount of p27 bound to cyclin D1-CDK4/6 complexes was higher in lysates of NHF transfected with id3-siRNAs than in control conditions (Figure 5b ), indicating that the excess of p27 resulting from the reduced downregulation of p27 in Id3-siRNA treated cells, likely associated with cyclin D1/CDK4/6 complexes ( Figure 5b ).
Then we examined the effect of Id3 silencing 24 h after injury namely during the G1/S transition and during the S-phase progression (Figure 5c, d and e) . By using real-time PCR (Figure 5c ) and Western blot experiments (Figure 5c ), we found that, 24 h after wounding, the expression of cyclin A was inhibited by more than 40% when cells were wounded in the presence of Id3-siRNA, indicating that the Id3-dependent inhibition of p27 blocked the G1/S transition. The inhibition of S-phase entry was verified by showing that Id3-siRNA inhibited by 45% the DNA synthesis, visualized by BrdU incorporation experiments (Figure 5e ).
Taken together our data show, for the first time, that Id3-mediated p27 transcriptional regulation is a critical event controlling the cell-cycle progression. The abrogation of p27 mRNA downregulation is sufficient to impair the cell-cycle entry and G1-phase progression.
To further dissect this point and to assess whether Id3 controlled the cell-cycle by targeting p27 expression, we tested the effect of Id3-siRNA on the proliferation of early passage 'primary' mouse embryonic fibroblasts (MEFs) containing a homozygous targeted deletion of 
A-A Chassot et al the p27 gene (passage 2-4) (Nakayama et al., 1996) and on their heterozygous counterparts (p27 þ /À). As shown in Figure 6a a real time PCR analysis showed that p27À/À MEFs were effectively devoid of p27. Growing cells were then transfected with Id3-siRNAs and Ct-siRNAs and Id3 and p27 expression were and Elk1 on p27 promoter activity. A p27kip1 promoter construct was co-transfected as described in 'Materials and methods' in the presence of (i) pcDNA3 vector (pcDNA), (ii) a pcDNA3 vector encoding wild-type Id3 (Id3), (iii) a pcDNA3 vector encoding a variant of Id3 in which the Serine 5 was replaced by alanine (Id3-Ala5) (iv) PJ3omega vectors encoding E12 (E12) and E47 (E47) added together (E12 þ E47) and (v) a pcDNA vectors encoding wt-ELK1 (ELK1). The luciferase activity was normalized by b-galactosidase activity. (d) ChIPs were performed on extracts from confluent HDF cells as described in 'Materials and methods'. Immunoprecipitation was performed using a non-relevant antibody (1) sepharose beads only (2) and a specific anti-ELK1 antibody (3) and primers spanning the p27kip1 promoter region were used for the PCR amplification. Lane 4 represents the oligonucleotidic fragment obtained after PCR amplification of the total genomic DNA before immunoprecipitation (input). (e) P27 promoter activity in the presence of plasmids encoding wild type (wt-ELK1) or a dominant-negative variant of ELK1 (dn-ELK1). P27 promoter activity measured after cotransfection of plasmids encoding wt-ELK1 (200 ng) and Id3 (200 ng) (ELK1 þ Id3). The pcDNA3 histograms represent the basal activity of p27 promoter (wt-p27prom) and of p27 promoter mutated on the À453/À439 ELK1 site (mut-p27 prom) (hatched histogram). The data in (c, d and e) are from a typical experiment selected among two individual ones.
A-A Chassot et al analysed in parallel in p27À/À and p27 þ /À MEFs after 36 h. Data presented in Figure 6b show that Id3 was expressed at equivalent levels in p27À/À and p27 þ /À cells and was efficiently inhibited (60% inhibition) after 36 h of transfection with Id3-siRNA. P27 was expressed at low levels in cycling p27 þ /À MEF and its expression increased significantly in Id3-siRNA-treated cells, supporting the idea that in MEF, like in HDF, p27 regulation also involves Id3. We finally observed that Id3 silencing inhibited about 50% the proliferation of cycling of p27 þ /À MEF as assessed by the incorporation of BrdU (Figure 6c ), but did not affect the proliferation of p27À/À MEFs, indicating that the regulation of p27 by Id3 was a key event in the cascade of events controlling cell growth.
Discussion
Decreased p27 expression is one of the earlier events observed when quiescent confluent cells are stimulated to proliferate in the presence of mitogenic stimuli (Malek et al., 2001; Kamura et al., 2004) . Most of the studies indicate that, in cycling cells, p27 is degraded during G1 and G1/S phases by mechanisms involving the ubiquitin-proteasome pathway (Pagano et al., 1995; Montagnoli et al., 1999; Malek et al., 2001; Kamura et al., 2004) . In this study, using a suitable woundhealing model that stimulates the synchronous cell-cycle entry of HDF upon injury, we clearly show that p27 decrease is transcriptional regulated and, as a novelty, we demonstrate that the transcriptional repressor Id3 plays a pivotal role in this process. However, although this transcriptional regulation appears crucial, it does not exclude the relevance of p27 protein degradation in cell-cycle commitment. Indeed we observed that, in our system, the inhibition of p27 protein degradation by proteasome inhibitors also prevented the cell-cycle (not shown). Together these observations suggest that the Id3-dependent transcriptional regulation and the proteasome post-translational degradation of p27 cooperate to allow an efficient protein p27 downregulation and the cell-cycle entry.
Id2/Id3 have been reported to regulate p27 in very specific contexts (Everly et al., 2004; Kee and BronnerFraser, 2005) ; however, their effect on p27 transcriptional control during cell proliferation had never been 
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A-A Chassot et al investigated. In our model, by using a siRNA approach we show that Id3 efficiently participates in the inhibition of p27 by inactivating the transcriptional activity of its promoter thereby leading to a downregulation of its mRNA and protein expression. It is worthnoting that in our wounding model, Id3 has no effect on p21 expression indicating that in this physiological situation, p27 is the major cyclin/Cdk inhibitor targeted by Id3. Under physiological conditions, Ids are transcriptional repressors of several transcription factors such as E2A, Ets1/2, SAPs, Pax(2-5), TCFs, myoD, (Yates et al., 1999; Trausch-Azar et al., 2004; Roberts et al., 2001 ) and E2A family members are their most frequent partners (Norton, 2000) . In our biological model, E2A family members do not participate to the regulation of p27 promoter and therefore are unlikely the partners of Id3 in this process. In contrast, reporter gene experiments and ChIP assays have shown that Id3 exerts its inhibitory effect on p27 promoter by antagonizing the action of Elk1, a TCF Ets-domain transcription factor. The involvement of Id3 in the negative regulation of TCF activity has been reported previously in the case of the c-fos promoter (Yates et al., 1999) . This inactivation participates to the inhibition of c-fos transcription after its classical early and transient stimulation by serum. Besides p27, Ids family members also participate to the transcriptional inhibition of p21cip1, another CKI. However, in contrast with the case of p27, this inhibitory mechanism involves E2A family members (Prabhu et al., 1997) , indicating that although p21 and p27 exert similar effects in the control of the cell-cycle, the pathways that regulate their expression are different.
Our study demonstrates that Id3-dependent p27 downregulation is really critical in the control of cell proliferation in wounded cells, because its inhibition prevents the cell-cycle commitment and progression. Chronologically, the first observed effect of Id3 silencing (apart from its p27 regulation) was the inhibition of the phosphorylation and degradation of the 'pocket proteins' pRb and p130. In cycling cells, the phosphorylation of the 'pocket proteins' is a prerequisite for cyclin E and A induction and G1/S transition (Sherr, 1995, 2002). In agreement with this notion, here we show that the inhibition of the 'pocket proteins' by Id3-siRNAs is associated with an inhibition of the G1/S transition as verified by the inhibition of cyclin A stimulation and DNA synthesis. The inhibition of 'pocket proteins' phosphorylation/ degradation in early-mid-G1 likely results from a reduced cyclin D1-associated kinase activity as demonstrated by the weaker degradation of p130, a highly specific physiological substrate of cyclin D1-kinase, observed in Id3-siRNA-treated HDF (Grana et al., 1998) . This reduced enzymatic activity is not a consequence of a decrease in cyclin D1 expression nor of an effect of Id3-siRNA on p16 (ink4A) (not shown), but could be owing to a higher association of p27 with cyclin-associated kinase in Id3-siRNA treated cells. The effects of p27 on cyclinD1-CDK4/6 activities are still unresolved. Some studies evoke that p27Kip1 and p21Cip1 function as obligate assembly factors for D cyclin-cdk4 complexes (Cheng et al., 1999) and that D cyclin-cdk4 complexes containing a single p27Kip1 or p21Cip1, are active (Blain et al., 1997; LaBaer et al., 1997) . Other studies argue that D cyclin-cdk4 complexes containing p27Kip1 or p21Cip1 are always inactive (Bagui et al., 2003) . The inhibition of p130 degradation that we observed in Id3-siRNA-treated cells seems to indicate that, in our biological context, the increased association of p27 with cyclin D1-associated kinase reduces its enzymatic activity.
Taken together our data show that the Id3-mediated p27 decrease is a crucial event for the cell-cycle progression and S-phase entry. The specificity of Id3 toward p27 is supported by experiments carried out in p27-deficient primary MEFs and showing that, in the absence of p27, Id3-siRNA does not anymore exert its antiproliferative effect.
After its down-regulation in early G1, the level of p27 mRNA steadily increased as soon as cells approached the G1-S transition. We observed that the amplitude of this second wave of p27 increase was significantly higher when Id3 was silenced, indicating that, under normal conditions, Id3 (besides its immediate function on p27 transcription) is also involved in the transcriptional machinery controlling the steady-state level of p27 at the G1/S boundary. It is worthnoting that the levels of Id3 measured 15-24 h after injury are lower than the ones measured immediately after injury, which probably explains why, in cells approaching the G1/S transition, Id3 does not inhibit p27 mRNA expression but only modulates its protein levels.
To conclude, this work reinforces the role of Id3 in p27 regulation and consequently in the cell-cycle progression. Id3 is involved in the control of the early degradation phase of p27 mRNA but also participates to the control of p27 mRNA stability at the G1/S boundary. P27 is not mutated in transformed cells but it presents low reduced expression in tumours (Okabe et al., 2001; Kudo et al., 2005) . Recent evidence suggests that Skp2, the specific recognition factor for p27 ubiquitination, is endowed of oncogenic properties (Bloom and Pagano, 2003) . Our study shows that, apart from the widely studied genes involved in p27 degradation, other genes responsible for the transcriptional control of p27, like Id3, might play a key role in cell proliferation and can be the target of genetic alterations leading to deregulated proliferation putatively responsible for tumour development.
Materials and methods
Cell culture NIH 3T3 cell line obtained from American Type Culture Collection were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with fetal calf serum, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (20 mM), glutamine (2 mM), penicillin (1000 U/ml), and streptomycin (1000 U/ml). Normal Dermal Fibroblasts (HDF) were isolated from healthy neonatal foreskin according to Rheinwald and Green, (1975) and cultured in DMEM supplemented with 10% bovine calf serum, HEPES (20 mM), glutamine (2 mM), penicillin (1000 U/ml), and streptomycin (1000 U/ml). P27-deficient (p27À/À) MEF and their p27 þ /À heterozygote counterparts are primary MEFs isolated from p27 knockdown mice embryo (Nakayama et al., 1996) and cultured at low passage (2-4). Cells were grown into DMEM supplemented with 10% bovine calf serum HEPES (20 mM), glutamine (2 mM), penicillin (1000 U/ml), streptomycin (1000 U/ml).
Confluent HDF were stimulated to proliferate by calibrated scratches (injuries) using a device that allow wounding up to 40% of the cell population and cells were harvested at the indicated times. For the replating experiments, confluent cells were trypsinized and diluted 1 : 4 in fresh medium. For serum stimulation experiment, low-density cell cultures were depleted 36 h in DMEM supplemented with 0.1% bovine serum albumin, HEPES (20 mM), glutamine (2 mM), penicillin (1000 U/ml), streptomycin (1000 U/ml) before addition of serum (20% final).
Reagents and antibodies DMEM, trypsin, EDTA, HEPES, glutamine, penicillin, and streptomycin were purchased from LifeTechnologies (Carlsbad, CA, USA). Bovine calf serum was obtained from Hyclone. bovine serum albumin, Hoechst 33258, actinomycin D and cycloheximide were purchased from Sigma (St Louis, MO, USA). Anti-Id3 (C20), anti-p21 (C19), anti-p27 (C19) and anti-p130 (C20) antibodies were obtained from SantaCruz (tebu-bio, Le Perrey en Yvelines, France). Monoclonal anti-cyclin D1 (DCS-6) antibody was from Transduction Laboratories (Lexington, KY, USA); monoclonal anti-cyclin A was from Novocastra and monoclonal anti-BrdU antibody was from Roche/Amersham (Les Ulis, France). Horseradish peroxidase-conjugated and FITC-conjugated antibodies IgG were purchased from Dako (Glostrup, Denmark).
Plasmids
The promoter region of p27 Kip1 was described in Minami et al. (1997) and was a generous gift of Dr Sakai. The pcDNA3 constructs encoding wild type Id3 and serine to alanine 5 mutated Id3 (Id3-Ala5) was generated as described previously (Deed et al., 1997) and provide by Dr JD Norton. The PJ3omega plasmids encoding E12 and E47 were a gift of Dr R Stein and were previously described by Sharma (Sharma et al., 1997) . The pcDNA3 plasmids encoding wt-ELK1 and a dominant-negative variant (ELK1-dn) were kindly provided by Dr Robert Hipskind and were described elsewhere (Janknecht et al., 1993) .
The mutation of the Elk1 site in p27 promoter was performed using the 'quick change direct mutagenesis' (Stratagene, La Jolla, CA, USA) according the manufacturer instruction. The primer used for mutagenesis was CGTCAGCCTCCCTT CGGATCCGAATTCGCCACTAAAAAAAGG.
Transfection and luciferase assay NIH 3T3 murine fibroblasts were seeded in 48-wells plates, at a density of 25000 cells/mm 2 , and were co-transfected using the calcium phosphate technique with 0.1 mg of the plasmids containing wt or ELK1-mutated p27
Kip1 promoter in the presence of 0.3 mg of each of the different expression vectors encoding Id3, Id3-Ala5 but also E12, E47, wt-ELK1 and dn-ELK1. Cells were harvested 24 h after transfection and luciferase activity assay was performed accordingly to the manufacturer's instruction (Promega, Madison, WI, USA). Transfection efficiency was normalized using a pCMV-bGal.
RNA extraction and real-time quantitative PCR Total RNA was isolated from HDF according to Rezzonico et al. (1995) . mRNA expression level was quantified by realtime one-step PCR performed in an ABI PRISM 5700 Sequence Detector System (Applied Biosystems, Foster City, CA, USA) using the SYBR Green detection protocol as outlined by the manufacturer. Gene-specific primers were designed using the Primer Express software (Applied Biosystems). The primer sequences can be obtained upon request. Relative expression level of target genes was normalized for RNA concentrations with two different house-keeping genes (GAPDH and a-actin). mRNA values are expressed as arbitrary units and represent7standard deviation (s.d.) of triplicates, and are representative of two independent experiments. Small RNA interference experiments (siRNA) Confluent HDF were transfected for 24 h with 100 nM siRNA, using the LIPOFECTAMINE reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer procedure then were submitted to injury. In the case of p27-/-and p27 þ /-primary MEFs, the cells (50% of confluence) were transfected as described above, and were left in culture for 12 additional hours after siRNA transfection. Id3-siRNA sequence was described previously (Kowanetz et al., 2004) and controlsiRNA (Ct-siRNA) targeted the firefly luciferase mRNA (Busca et al., 2005) .
Protein extracts and Immunoblotting analysis
The HDF lysates preparation and Western blot procedures were described previously (Turchi et al., 2002) 
BrdU-labelling experiments
Confluent siRNA transfected HDF were wounded. After 18 h, BrdU (10 mg/ml) was added and cells were collected 6 h later (24 h after injury), cells were fixed in 3.7% paraformaldehyde for 20 min at room temperature, rinsed in phosphate-buffered saline (PBS) and the chromatin was rendered accessible by a 10 min treatment with HCl (2 N). Cells were extensively washed with PBS, then incubated 10 min at room temperature with PBS þ 0.1% Tween, washed five times with PBS and finally blocked for 30 min at room temperature in PBS þ 0.1% BSA. Cells were incubated with anti-BrdU antibody (1/10001) for 2 h at room temperature, washed extensively with PBS and incubated with anti-mouse FITC-conjugated antibodies (1/ 501) for 1 h at room temperature. Hoechst (1/10001) was added for 10 min, cells were washed in PBS in distilled water and mounted in Mowiol (Calbiochem, Meudon, France). In the case of p27-/-and p27 þ /-MEFs, BrdU (10 mg/ml) was added 24 h after siRNA transfection and cells were maintained in culture for 12 additional hours. Cells were fixed in 3.7% formaldehyde and incubated with anti-BrdU antibodies as described above. BrdU-positive HDF and MEF were counted using the ImageJ Software (http://rsb.info.nih.gov/ij).
ChIP assay
Confluent HDF were treated with 1% formaldehyde for 5 min at 371C and for 30 min at 41C. Next, cells were harvested and suspended in the lysis buffer (10 mM Hepes, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, 0.1% NP-40, and protease inhibitors). After 10 min incubation on ice, cells were centrifuged (5000 r.p.m., 5 min at 41C) to pellet the nuclei. Nuclei were then suspended in the nuclei lysis buffer (50 mM Tris-HCl, pH 8.1, 10 mM ethylenediaminetetraacetic acid, 1% sodium dodecyl sulphate and protease inhibitors) and incubated on ice for 10 min. The sheared chromatin was then immunoprecipitated using (or not) a specific polyclonal anti-ELK1 antibody (1/200), (Santa Cruz I120). After immunoprecipitation, the crosslink was reverted by heat treatment (671C overnight) and proteinase K digestion. The gen omic captured fragments were then recovered by phenol-chloroform extraction. The captured p27kip1 promoter fragments were identified by PCR analysis using specific primers spanning the promoter. Thirty cycles of PCR were performed and the amplified products were analysed on a 2% agarose gel. The oligonucleotides to amplify p27kip1 promoter region were 5 0 -GTTTGTTGGCAGCAGTACC-3 0 (forward) and 5 0 -CCG CTGATCAAATGGACTGG-3 0 (reverse).
